Nowacka-Zawisza M - Search Results

1

Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.

Nowacka-Zawisza M, Bryś M, Romanowicz-Makowska H, Kulig A, Krajewska WM. Nowacka-Zawisza M, et al. Cancer Detect Prev. 2008;32(2):144-8. doi: 10.1016/j.cdp.2008.06.005. Epub 2008 Jul 16. Cancer Detect Prev. 2008. PMID: 18632222

2

Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer.

Nowacka-Zawisza M, Bryś M, Hanna RM, Zadrozny M, Kulig A, Krajewska WM. Nowacka-Zawisza M, et al. Pol J Pathol. 2006;57(2):83-9. Pol J Pathol. 2006. PMID: 17019970

3

Genetic instability in the RAD51 and BRCA1 regions in breast cancer.

Nowacka-Zawisza M, Bryś M, Romanowicz-Makowska H, Kulig A, Krajewska WM. Nowacka-Zawisza M, et al. Cell Mol Biol Lett. 2007;12(2):192-205. doi: 10.2478/s11658-006-0063-x. Epub 2006 Dec 18. Cell Mol Biol Lett. 2007. PMID: 17180310 Free PMC article.

4

Loss of heterozygosity in the RAD54B region is not predictive for breast carcinomas.

Bryś M, Nowacka-Zawisza M, Romanowicz-Makowska H, Zadrozny M, Kulig A, Krajewska WM. Bryś M, et al. Pol J Pathol. 2007;58(1):3-6. Pol J Pathol. 2007. PMID: 17585536

5

Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.

Nowacka-Zawisza M, Brys M, Romanowicz-Makowska H, Kulig A, Krajewska WM. Nowacka-Zawisza M, et al. Pathol Int. 2008 May;58(5):275-81. doi: 10.1111/j.1440-1827.2008.02223.x. Pathol Int. 2008. PMID: 18429825

6

Polymorphisms of homologous recombination RAD51, RAD51B, XRCC2, and XRCC3 genes and the risk of prostate cancer.

Nowacka-Zawisza M, Wiśnik E, Wasilewski A, Skowrońska M, Forma E, Bryś M, Różański W, Krajewska WM. Nowacka-Zawisza M, et al. Anal Cell Pathol (Amst). 2015;2015:828646. doi: 10.1155/2015/828646. Epub 2015 Aug 3. Anal Cell Pathol (Amst). 2015. PMID: 26339569 Free PMC article.

7

Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.

Nowacka-Zawisza M, Forma E, Walczak M, Różański W, Bryś M, Krajewska WM. Nowacka-Zawisza M, et al. Med Oncol. 2015 Nov;32(11):246. doi: 10.1007/s12032-015-0691-y. Epub 2015 Oct 3. Med Oncol. 2015. PMID: 26433958 Free PMC article.

8

The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.

Starska K, Forma E, Nowacka-Zawisza M, Lewy-Trenda I, Ciesielski P, Pietruszewska W, Skóra M, Bryś M. Starska K, et al. Among authors: nowacka zawisza m. Tumour Biol. 2016 Apr;37(4):4541-57. doi: 10.1007/s13277-015-4276-3. Epub 2015 Oct 27. Tumour Biol. 2016. PMID: 26503213

9

Significance of TGFBR3 allelic loss in the deregulation of TGFβ signaling in primary human endometrial carcinomas.

Zakrzewski PK, Nowacka-Zawisza M, Semczuk A, Rechberger T, Gałczyński K, Krajewska WM. Zakrzewski PK, et al. Among authors: nowacka zawisza m. Oncol Rep. 2016 Feb;35(2):932-8. doi: 10.3892/or.2015.4400. Epub 2015 Nov 5. Oncol Rep. 2016. PMID: 26548418

10

RAD51 and XRCC3 Polymorphisms Are Associated with Increased Risk of Prostate Cancer.

Nowacka-Zawisza M, Raszkiewicz A, Kwasiborski T, Forma E, Bryś M, Różański W, Krajewska WM. Nowacka-Zawisza M, et al. J Oncol. 2019 May 2;2019:2976373. doi: 10.1155/2019/2976373. eCollection 2019. J Oncol. 2019. PMID: 31186630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page